Skip to main content
. Author manuscript; available in PMC: 2017 Feb 1.
Published in final edited form as: Eur Urol. 2015 Jul 26;69(2):345–351. doi: 10.1016/j.eururo.2015.07.006

Table 1. Most common a any-grade treatment-related adverse events (TRAEs) in patients with metastatic renal cell carcinoma receiving long-term sunitinib according to interval analysis.

Any-grade TRAE Patients, n (%)

0–<6 mo
(N = 807)
0–<1 yr
(N = 807)
1–<2 yr
(N = 807)
2–<3 yr
(N = 807)
3–<4 yr
(N = 365)
4–<5 yr
(N = 168)
5–<6 yr
(N = 77)
Any 785 (97) 796 (99) 783 (97) 767 (95) 340 (93) 157 (93) 72 (94)
Diarrhea 411 (51) 533 (66) 481 (60) 378 (47) 153 (42) 65 (39) 29 (38)
Fatigue 386 (48) 433 (54) 359 (44) 317 (39) 130 (36) 56 (33) 25 (32)
Dysgeusia 257 (32) 281 (35) 170 (21) 113 (14) 40 (11) 15 (9) 8 (10)
Stomatitis 261 (32) 288 (36) 156 (19) 86 (11) 25 (7) 17 (10) 12 (16)
Nausea 245 (30) 302 (37) 195 (24) 147 (18) 53 (15) 26 (15) 10 (13)
Hand–foot syndrome 242 (30) 320 (40) 311 (39) 251 (31) 106 (29) 52 (31) 22 (29)
Hypertension 222 (28) 276 (34) 230 (29) 204 (25) 94 (26) 46 (27) 23 (30)
Decreased appetite 214 (27) 262 (32) 167 (21) 113 (14) 34 (9) 17 (10) 7 (9)
Dyspepsia 220 (27) 264 (33) 182 (23) 136 (17) 59 (16) 27 (16) 16 (21)
Mucosal inflammation 220 (27) 248 (31) 152 (19) 100 (12) 40 (11) 22 (13) 8 (10)
Rash 152 (19) 206 (26) 121 (15) 77 (10) 22 (6) 15 (9) 5 (6)
Thrombocytopenia 149 (18) 184 (23) 84 (10) 47 (6) 18 (5) 3 (2) 1 (1)
Vomiting 141 (17) 175 (22) 109 (14) 72 (9) 20 (5) 14 (8) 3 (4)
Hair color changes 125 (15) 156 (19) 142 (18) 135 (17) 62 (17) 29 (17) 11 (14)
Asthenia 110 (14) 136 (17) 109 (14) 76 (9) 30 (8) 11 (7) 5 (6)
Neutropenia 110 (14) 142 (18) 118 (15) 70 (9) 37 (10) 12 (7) 4 (5)
Skin discoloration 102 (13) 127 (16) 84 (10) 59 (7) 29 (8) 12 (7) 4 (5)
Epistaxis 94 (12) 130 (16) 82 (10) 50 (6) 18 (5) 5 (3) 2 (3)
Pain in extremity 91 (11) 141 (17) 115 (14) 85 (11) 34 (9) 16 (10) 4 (5)
Hypothyroidism 46 (6) 110 (14) 231 (29) 241 (30) 118 (32) 55 (33) 32 (42)
a

Occurring in at least 15% of patients in at least one time interval.